Human ghrelin ameliorates organ injury and improves survival after radiation injury combined with severe sepsis

Molecular Medicine

Volumn 15, Issue 11-12, 2009, Pages 407-414

  Shah, Kavin G ^a   Wu, Rongqian ^a   Jacob, Asha ^a   Blau, Steven A ^a,b   Ji, Youxin ^a   Dong, Weifeng ^a   Marini, Corrado P ^a,c   Ravikumar, Thanjavur S ^a,c   Coppa, Gene F ^a   Wang, Ping ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SPECTRUM HEALTH   (United States)

^c GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GHRELIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; EXPERIMENTAL RAT; GENE EXPRESSION; HISTOPATHOLOGY; KIDNEY INJURY; LIVER INJURY; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; RAT; SEPSIS; SURVIVAL TIME; VAGOTOMY; WHOLE BODY RADIATION;

ANALYSIS OF VARIANCE; ANIMALS; CECUM; DISEASE MODELS, ANIMAL; GHRELIN; HUMANS; INTERLEUKIN-6; KAPLAN-MEIERS ESTIMATE; LIVER; MALE; NOREPINEPHRINE; PEROXIDASE; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73249141375     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00100     Document Type: Article

References (53)

1. Flynn DF, Goans RE. (2006) Nuclear terrorism: triage and medical management of radiation and combined-injury casualties. Surg. Clin. North Am. 86:601-36.
2. Remick DG. (2007) Pathophysiology of sepsis. Am. J. Pathol. 170:1435-44.
3. Howell G, Tisherman SA. (2006) Management of sepsis. Surg. Clin. North Am. 86:1523-39.
4. Powers J, Jacobi J. (2006) Pharmacologic treatment related to severe sepsis. AACN Adv. Crit. Care. 17:423-32.
5. Jenkins I. (2006) Evidence-based sepsis therapy: a hospitalist perspective. J. Hosp. Med. 1:285-95.
6. Bernard GR, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
7. Martin GS, Mannino DM, Eaton S, Moss M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546-54.
8. Danai PA, Sinha S, Moss M, Haber MJ, Martin GS. (2007) Seasonal variation in the epidemiology of sepsis. Crit. Care Med. 35:410-5.
9. Strehlow MC, Emond SD, Shapiro NI, Pelletier AJ, Camargo CA Jr. (2006) National study of emergency department visits for sepsis, 1992 to 2001. Ann. Emerg. Med. 48:326-31.
10. Angus DC, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-10.
11. Kojima M, et al. (1999) Ghrelin is a growthhormone-releasing acylated peptide from stomach. Nature. 402:656-60.
12. Arvat E, et al. (2000) Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J. Endocrinol. Invest. 23:493-5.
13. Date Y, et al. (2000) Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem. Biophys. Res. Commun. 275:477-80.
14. Nass R, et al. (2000) Intracerebroventricular administration of the rat growth hormone (GH) receptor antagonist G118R stimulates GH secretion: evidence for the existence of short loop negative feedback of GH. J. Neuroendocrinol. 12:1194-9.
15. Cowley MA, Grove KL. (2004) Ghrelin-Satisfying a hunger for the mechanism. Endocrinol. 145:2604-6.
16. Kojima M, Kangawa K. (2005) Ghrelin: structure and function. Physiol. Rev. 85:495-522.
17. Wang G, Lee HM, Englander E, Greeley GH Jr. (2002) Ghrelin-not just another stomach hormone. Regul. Pept. 105:75-81.
18. Wu R, et al. (2007) Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann. Surg. 245:480-6.
19. Wu R, Zhou M, Cui X, Simms HH, Wang P. (2004) Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am. J. Physiol. Heart Circ. Physiol. 287:H1296-302.
20. Wu R, et al. (2005) Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovasc. Res. 68:318-26.
21. Wu R, et al. (2007) Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am. J. Respir. Crit. Care Med. 176:805-13.
22. National Research Council. (1996) Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academy Press. 118 pp.
23. Katanyutanon S, Wu R, Wang P. (2008) The effect of whole-body radiation on blood levels of gastrointestinal peptides in the rat. Int. J Clin. Exp. Med. 1:332-7.
24. Wu R, et al. (2009) Reversing established sepsis in rats with human vasoactive hormone adreno-medullin and its binding protein. Mol. Med. 15:28-33.
25. Dwivedi AJ, et al. (2007) Adrenomedullin and adrenomedullin binding protein-1 prevent acute lung injury after gut ischemia-reperfusion. J Am. Coll. Surg. 205:284-93.
26. Wu R, et al. (2007) Ghrelin inhibits sympathetic nervous activity in sepsis. Am. J. Physiol. Endocrinol. Metab. 293:E1697-702.
27. Yang S, Zhou M, Chaudry IH, Wang P. (2001) Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of alpha2-adrenoceptors. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G1014-21.
28. Zhou M, et al. (2001) The role of Kupffer cell alpha(2)-adrenoceptors in norepinephrine-induced TNF-alpha production. Biochim. Biophys. Acta. 1537:49-57.
29. Zhou M, Das P, Simms HH, Wang P. (2005) Gutderived norepinephrine plays an important role in up-regulating IL-1beta and IL-10. Biochim. Biophys. Acta. 1740:446-52.
30. Turai I, Veress K, Gunalp B, Souchkevitch G. (2004) Medical response to radiation incidents and radionuclear threats. BMJ. 328:568-72.
31. Van Der Lely AJ, Tschop M, Heiman ML, Ghigo E. (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25:426-57.
32. Hattori N, et al. (2001) GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrinol. Metab. 86:4284-91.
33. Sakata I, et al. (2003) Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci. Lett. 342:183-6.
34. Papotti M, et al. (2000) Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 85:3803-7.
35. Shuto Y, et al. (2001) Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHSR exists in the hypothalamus, pituitary and stomach of rats. Life Sci. 68:991-6.
36. Taub DD. (2008) Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam. Horm. 77:325-46.
37. Koo DJ, Chaudry IH, Wang P. (1999) Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. J. Surg. Res. 83:151-7.
38. Hotchkiss RS, Karl IE. (2003) The Pathophysiology and Treatment of Sepsis. N. Engl. J. Med. 348:138-50.
39. Holler E, et al. (1990) Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood. 75:1011-6.
40. Hong JH, , et al. (1999) Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. Int. J. Radiat. Biol. 75:1421-7.
41. Linard C, et al. (2004) Acute induction of inflammatory cytokine expression after gammairradiation in the rat: effect of an NF-kappaB inhibitor. Int. J. Radiat. Oncol. Biol. Phys. 58:427-34.
42. Ran XZ, et al. (2007) Effects of serum from rats with combined radiation-burn injury on the growth of hematopoietic progenitor cells. J. Trauma. 62:193-8.
43. Bednarek MA, et al. (2000) Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43:4370-6.
44. Miksa M, Wu R, Zhou M, Wang P. (2005) Sympathetic excitotoxicity in sepsis: pro-inflammatory priming of macrophages by norepinephrine. Front Biosci. 10:2217-29.
45. Tracey KJ. (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117:289-96.
46. Matsumura K, Tsuchihashi T, Fujii K, Abe I, Iida M. (2002) Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension. 40:694-9.
47. Yasuda T, Masaki T, Kakuma T, Yoshimatsu H. (2003) Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neurosci. Lett. 349:75-8.
48. Nagaya N, et al. (2004) Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 110:3674-9.
49. Date Y, et al. (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 123:1120-8.
50. Wu R, et al. (2008) Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion. PLoS ONE. 3:e2026.
51. Yanagida H, et al. (2008) Effects of ghrelin on neuronal activity in the ventromedial nucleus of the hypothalamus in infantile rats: an in vitro study. Peptides. 29:912-8.
52. Takayama K, et al. (2007) Expression of c-Fos protein in the brain after intravenous injection of ghrelin in rats. Neurosci. Lett. 417:292-6.
53. Obay BD, Tasdemir E, Tumer C, Bilgin HM, Atmaca M. (2008) Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model. Peptides. 29:448-55.